BioSpace News Archive

Business

IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*

IPA, an artificial intelligence-driven biotherapeutic research and technology company, reported financial results for its second quarter of the 2024 fiscal year, which ended October 31, 2023.

December 14, 2023
·
8 min read
Biotech Bay

Imperative Care Announces First-In-Human Study of Novel Implant Designed to Enable Single Antiplatelet Therapy After Aneurysm Treatment

Imperative Care today announced the initiation of a first-in-human clinical study for its novel stent system designed to only require single antiplatelet therapy for patients undergoing stent-assisted treatment of wide-neck intracranial aneurysms.

December 14, 2023
·
3 min read
BioMidwest

CinFina Pharma, a CinRx Portfolio Company, Introduces Scientific Advisory Board with Deep Metabolic Expertise

CinFina Pharma, CinRx Pharma’s portfolio company dedicated to expanding treatment options for obesity and metabolic diseases, announced the scientific advisory board members for the company’s multi-asset pipeline.

December 14, 2023
·
5 min read
BioMidwest

Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals

Baxter International Inc., an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous bag recycling program pilot.

December 14, 2023
·
5 min read
Business

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow

Applied DNA Sciences, Inc. and Kudo Biotechnology announced their entry into a joint development agreement to integrate Applied DNA’s Linea™ IVT platform into Kudo Bio’s commercial mRNA manufacturing workflows.

December 14, 2023
·
6 min read
BioMidwest

Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC RegionsPricing Provides AmnioWrap2™ Reimbursement in All MAC Regions

BioStem Technologies Inc. announced that the Center for Medicare Services has established national pricing for its product, AmnioWrap2™, in all Medicare Administrative Contractors regions.

December 14, 2023
·
6 min read
Business

Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma

Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) and Biolojic Design Ltd. (“Biolojic”) today announced an exclusive license agreement to develop a potential novel antibody-based therapy for the treatment of Atopic Dermatitis and Asthma.

December 14, 2023
·
6 min read
Clene Announces Peer-Reviewed Publication Describing CNM-Au8 Brain Target Engagement In Neurodegenerative Diseases

Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., today announced the publication of a peer-reviewed article describing brain target engagement by CNM-Au8®, the company’s lead drug candidate.

December 14, 2023
·
6 min read
BioMidwest

Neogen®, Cat Fanciers’ Association Collaborate to Advance Feline DNA Testing

Neogen Corporation announced that it is collaborating with the Cat Fanciers’ Association, a leading authority in feline advocacy.

December 14, 2023
·
2 min read
Biotech Beach

Ambrx to be Added to the NASDAQ Biotechnology Index (NBI)

Ambrx Biopharma, Inc., or Ambrx, announced that the Company will be added to the NASDAQ Biotechnology Index, effective prior to the market open on Monday, December 18, 2023.

December 14, 2023
·
3 min read